全球肠外营养市场 - 市场规模、份额、成长分析：按消费者、最终用户划分 - 产业预测（2023-2030）

Global Parenteral Nutrition Market Size, Share, Growth Analysis, By Consumer(Children and Newborns, and Adults), By End user(Clinics, Hospitals) - Industry Forecast 2023-2030

出版日期: 2023年10月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计2021年全球肠外营养市场规模为63.3亿美元，2022年为67.1亿美元。预计该市场在预测期（2023年至2030年）将以6.0%的年复合成长率扩张，到2030年将成长至107亿美元。

全球肠外营养市场在过去年度中经历了显着成长，预计未来将继续扩大。推动全球肠外营养市场成长的主要因素之一是慢性病和胃肠道疾病的盛行率不断增加。癌症、克隆氏症和短肠症候群等疾病需要使用肠外营养来确保足够的营养并支持患者康復。此外，容易出现营养不良和相关併发症的老年人口的增加也促进了市场的成长。推动市场扩张的另一个因素是肠外营养配方和技术的进步。製造商专注于开发创新产品，以改善患者治疗效果、减少併发症并提高给药便利性。例如，具有可客製化营养组合的多室袋的推出简化了肠外营养溶液的製备过程，使医疗保健专业人员和患者受益。然而，全球肠外营养市场也面临一些挑战。一个重要的障碍是与长期肠外营养治疗相关的感染疾病和併发症的风险。导管相关的血流感染和代谢併发症对患者构成重大风险，需要严格的感染控制措施和仔细监测。此外，肠外营养解决方案和相关设备的高成本可能会限制市场成长，特别是在医疗保健预算有限的新兴市场。

创新配方、改良营养组合和先进输送系统的开发正在提高肠外营养治疗的安全性和有效性。这些进步使肠外营养给药对医疗保健提供者来说更加方便，并且患者的耐受性更好。

人们越来越认识到营养在整体健康和疾病管理中的重要性。人们对营养在患者预后中的作用的认识不断加深，导致对肠外营养治疗作为综合医疗保健一部分的需求增加。

有关肠外营养治疗的法规因地区而异，指南也不标准化，这给製造商和医疗保健提供者带来了挑战。协调法律规范和製定循证指南对于确保安全有效地给药肠外营养至关重要。

长期依赖肠外营养可出现肝功能障碍、体液失衡及电解质异常等併发症。必须仔细管理这些限制和併发症，以确保肠外营养的最佳使用并最大限度地降低患者的风险。

该报告研究了全球肠外营养市场，并提供了市场概述，包括消费者、最终用户、地区的趋势以及参与市场的公司概况。

主要企业简介
- Fresenius Kabi
- B. Braun Melsungen AG
- Baxter International Inc.
- Grifols SA
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.
- Aculife Healthcare Pvt. Ltd.
- Vifor Pharma
- Sichuan Kelun Pharmaceutical Co., Ltd.
- ALLERGAN
- Claris Lifesciences Limited
- Actavis plc
- ABBOTT
- AstraZeneca
- Medtronic
- Beximco Pharmaceuticals Ltd.
- Sichuan Luye Pharmaceutical Co., Ltd.
- ICU Medical, Inc.
- JW Pharmaceutical Corporation
- Hospira, Inc.

简介目录

Product Code: SQMIG35C2016

Global Parenteral Nutrition Market size was valued at USD 6.33 Billion in 2021 and is poised to grow from USD 6.71 Billion in 2022 to USD 10.7 Billion by 2030, at a CAGR of 6.0% during the forecast period (2023-2030).

The global parenteral nutrition market has experienced significant growth over the past years and is expected to continue expanding in the coming years. One of the key drivers fueling the growth of the global parenteral nutrition market is the increasing prevalence of chronic diseases and gastrointestinal disorders. Conditions such as cancer, Crohn's disease, and short bowel syndrome necessitate the use of parenteral nutrition to ensure adequate nutrition and support patient recovery. Moreover, the rising geriatric population, who are more prone to malnutrition and related complications, has contributed to the market growth. Another factor driving market expansion is the advancements in parenteral nutrition formulations and technologies. Manufacturers are focusing on developing innovative products that improve patient outcomes, reduce complications, and enhance the ease of administration. For instance, the introduction of multi-chamber bags that allow for customized nutrient combinations has simplified the process of preparing parenteral nutrition solutions, benefiting both healthcare professionals and patients. However, the global parenteral nutrition market also faces several challenges. One of the significant hurdles is the risk of infections and complications associated with long-term parenteral nutrition therapy. Catheter-related bloodstream infections and metabolic complications pose substantial risks to patients, requiring stringent infection control measures and careful monitoring. Furthermore, the high cost of parenteral nutrition solutions and associated equipment can limit market growth, especially in developing regions with limited healthcare budgets.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Parenteral Nutrition Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

The global parenteral nutrition market is segmented on the basis of consumer, end user, and region. By consumer, the market is segmented into Children and Newborns, and Adults. By end user, the market is segmented into Clinics, Hospitals, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Parenteral Nutrition Market Dynamics

Drivers of the Global Parenteral Nutrition Market

Technological Advancements in Parenteral Nutrition Products

The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Increasing Awareness about Clinical Nutrition

There is a growing awareness of the importance of nutrition in overall health and disease management. This increased understanding of the role of nutrition in patient outcomes has led to a higher demand for parenteral nutrition therapy as a part of comprehensive healthcare.

Restraints in the Global Parenteral Nutrition Market

Regulatory Constraints and Lack of Standardization

Variations in regulations and lack of standardized guidelines for parenteral nutrition therapy across different regions pose challenges for manufacturers and healthcare providers. Harmonization of regulatory frameworks and the development of evidence-based guidelines are essential for ensuring safe and effective administration of parenteral nutrition.

Potential Complications and Limitations of Long-term Use

Prolonged dependence on parenteral nutrition may present complications such as liver dysfunction, fluid imbalances, and electrolyte abnormalities. These limitations and complications need to be carefully managed to ensure the optimal use of parenteral nutrition and minimize risks to patients.

Market Trends of Global Parenteral Nutrition Key

Integration of Digital Health Technologies: Digital health technologies, such as mobile applications, connected devices, and telehealth solutions, are being integrated into parenteral nutrition therapy. These technologies enable remote monitoring, real-time data collection, and improved communication between patients, caregivers, and healthcare providers, leading to better patient management and enhanced treatment outcomes.

Focus on Quality Control and Product Safety: With the increasing importance of patient safety, there is a growing focus on quality control and product safety in the manufacturing and administration of parenteral nutrition solutions. Companies are implementing stringent quality assurance processes, adhering to regulatory guidelines, and investing in technologies to ensure the safety and efficacy of their products.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Parenteral Nutrition Market by Consumer
- Market Overview
- Children and Newborns
- and Adults
Global Parenteral Nutrition Market by End user
- Market Overview
- Clinics
- Hospitals
- and Others
Global Parenteral Nutrition Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Fresenius Kabi (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Baxter International Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Grifols SA (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Otsuka Pharmaceutical Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Aculife Healthcare Pvt. Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Vifor Pharma (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ALLERGAN (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Claris Lifesciences Limited (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Actavis plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ABBOTT (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beximco Pharmaceuticals Ltd. (Bangladesh)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sichuan Luye Pharmaceutical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ICU Medical, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- JW Pharmaceutical Corporation (South Korea)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hospira, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments